Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Takeda Pharmaceutical Co., Ltd. (TKPHF)

  • SEC News
  • July 09, 2025, 10:46 UTC
  • 5

New Form 144 - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-09 AccNo: 0001977734-25-000004 Size: 4 KB

Comment Full text

Takeda Pharmaceutical Co., Ltd. (TKPHF)

  • SEC News
  • July 09, 2025, 10:44 UTC
  • 5

New Form 144 - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-09 AccNo: 0001977608-25-000004 Size: 4 KB

Comment Full text

Takeda Pharmaceutical Co., Ltd. (TKPHF)

  • SEC News
  • July 09, 2025, 10:42 UTC
  • 2

New Form 144 - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-09 AccNo: 0001811081-25-000003 Size: 4 KB

Comment Full text

Takeda Pharmaceutical Co., Ltd. (TKPHF)

  • SEC News
  • July 09, 2025, 10:39 UTC
  • 5

New Form 144 - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-09 AccNo: 0001977817-25-000004 Size: 4 KB

Comment Full text

Takeda Pharmaceutical Co., Ltd. (TKPHF)

  • SEC News
  • July 09, 2025, 10:37 UTC
  • 8

New Form 144 - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-09 AccNo: 0001977746-25-000004 Size: 4 KB

Comment Full text

Takeda Pharmaceutical Co., Ltd. (TKPHF)

  • SEC News
  • July 09, 2025, 10:34 UTC
  • 7

New Form 144 - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-09 AccNo: 0001977732-25-000004 Size: 4 KB

Comment Full text

Takeda Pharmaceutical Co., Ltd. (TKPHF)

  • SEC News
  • July 09, 2025, 10:32 UTC
  • 6

New Form 144 - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-09 AccNo: 0001977620-25-000004 Size: 4 KB

Comment Full text

Merck & Company Inc (MRK)

  • Business News
  • July 09, 2025, 10:31 UTC
  • 11

Merck to Acquire Verona Pharma, Expanding its Portfolio to IncludeOhtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade

Market reaction Comment Full text

Takeda Pharmaceutical Co., Ltd. (TKPHF)

  • SEC News
  • July 09, 2025, 10:30 UTC
  • 6

New Form 144 - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-09 AccNo: 0001977815-25-000004 Size: 4 KB

Comment Full text

Takeda Pharmaceutical Co., Ltd. (TKPHF)

  • SEC News
  • July 09, 2025, 10:27 UTC
  • 7

New Form 144 - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-09 AccNo: 0002009368-25-000004 Size: 4 KB

Comment Full text

Takeda Pharmaceutical Co., Ltd. (TKPHF)

  • SEC News
  • July 09, 2025, 10:24 UTC
  • 6

New Form 144 - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-09 AccNo: 0002011270-25-000004 Size: 4 KB

Comment Full text

Alto Ingredients Inc (ALTO)

  • SEC News
  • July 09, 2025, 10:23 UTC
  • 7

New Form 3 - Alto Ingredients, Inc. Filed: 2025-07-09 AccNo: 0001213900-25-062170 Size: 3 KB

Comment Full text

GSK plc (GLAXF)

  • SEC News
  • July 09, 2025, 10:21 UTC
  • 9

New Form 6-K - GSK plc Filed: 2025-07-09 AccNo: 0001654954-25-007862 Size: 1 MB

Comment Full text

Alto Ingredients Inc (ALTO)

  • SEC News
  • July 09, 2025, 10:21 UTC
  • 8

New Form 3 - Alto Ingredients, Inc. Filed: 2025-07-09 AccNo: 0001213900-25-062168 Size: 3 KB

Comment Full text

Takeda Pharmaceutical Co., Ltd. (TKPHF)

  • SEC News
  • July 09, 2025, 10:20 UTC
  • 9

New Form 144 - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-09 AccNo: 0001977689-25-000004 Size: 4 KB

Comment Full text
  • Previous
  • 369
  • 370
  • 371
  • 372
  • 373
  • Next

Search

News categories

  • Technical Exchange News(9684)
  • Event(407)
  • SEC News(159138)
  • FDA Approval(9147)
  • Company Report(721)
  • Business News(108266)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin